19.63
10.34%
1.84
시간 외 거래:
19.62
-0.010
-0.05%
전일 마감가:
$17.79
열려 있는:
$18.07
하루 거래량:
135.76K
Relative Volume:
0.84
시가총액:
$1.21B
수익:
-
순이익/손실:
$-42.21M
주가수익비율:
-22.06
EPS:
-0.89
순현금흐름:
$-33.16M
1주 성능:
+8.93%
1개월 성능:
-3.21%
6개월 성능:
+70.10%
1년 성능:
+94.55%
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
19.63 | 1.21B | 0 | -42.21M | -33.16M | -0.89 |
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-07-27 | 개시 | Stephens | Overweight |
2021-03-11 | 개시 | Maxim Group | Buy |
2021-01-26 | 재확인 | H.C. Wainwright | Buy |
2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Pulse Biosciences (NASDAQ:PLSE) Trading 6.1% HigherShould You Buy? - MarketBeat
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Pulse Biosciences to Present Nano-PFA Technology at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Barclays PLC Buys 23,738 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Geode Capital Management LLC - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded to "Sell" at StockNews.com - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com - Defense World
Franklin Resources Inc. Buys New Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Investment Report - Stock Traders Daily
State Street Corp Increases Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
State Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading Down 2.2%Time to Sell? - MarketBeat
Pulse Biosciences: Constructive On Nano-Pulse Assets (NASDAQ:PLSE) - Seeking Alpha
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap UpShould You Buy? - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded at StockNews.com - MarketBeat
Pulse Biosciences Triggers $66M Warrant Redemption After Stock Price Surge Above $16.50 - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $588,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) On The My Stocks Page - Stock Traders Daily
Insider Selling: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells 50,000 Shares of Stock - MarketBeat
Pulse Biosciences' former CEO Barrett Burke Thomas sells $871,000 in stock - Investing.com Canada
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants - Business Wire
Pulse Biosciences' Major Shareholder Exercises $58.4M in Warrants, Boosts Ownership to 70% - StockTitan
Insider Trading Insights: Key Buys and Sells from Pulse Biosciences, Centene and More - mediahousepress
Pulse Biosciences director Robert Duggan purchases $949,298 in stock By Investing.com - Investing.com UK
Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Buys $949,298.08 in Stock - MarketBeat
Pulse Biosciences director Robert Duggan purchases $949,298 in stock - Investing.com
Pulse Biosciences (NASDAQ:PLSE) Trading 5.3% HigherStill a Buy? - MarketBeat
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery - BioSpace
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up on Insider Buying Activity - Defense World
Charles Schwab Investment Management Inc. Has $2.60 Million Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Robert Duggan Spends US$972k On Pulse Biosciences Stock - Yahoo Finance
Executive Co-Chairman of Pulse Biosciences Robert Duggan Buys More Stock - Simply Wall St
Insider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases 56,054 Shares of Stock - MarketBeat
StockNews.com Upgrades Pulse Biosciences (NASDAQ:PLSE) to Sell - Defense World
Pulse Biosciences director Robert Duggan buys $972,343 in stock By Investing.com - Investing.com Canada
Positive Data Presented for Pulse Biosciences’ nano-PFA Tech - MPO-mag
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop - Yahoo Finance
Pulse Biosciences Welcomes New Executive Team Members - MPO-mag
(PLSE) Long Term Investment Analysis - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.4%What's Next? - MarketBeat
Pulse Biosciences announces CEO departure and interim leadership By Investing.com - Investing.com Australia
Pulse Biosciences announces CEO departure and interim leadership - Investing.com
Pulse Biosciences CEO Resigns Amid Leadership Transition - TipRanks
Pulse Biosciences, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
펄스 바이오 주식 (PLSE) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
자본화:
|
볼륨(24시간):